Cardiovascular Disease Drugs Market Research Reports

"...... uring the forecast years. Cilostazol is a quinolinone-derivative medication used in the alleviation of the symptoms of intermittent claudication in individuals with peripheral vascular disease. It is manufactured by Otsuka Pharmaceutica......"

"...... wder and whose CAS number is 134523-03-8. The global Atorvastatin Calcium market is projected to grow from US$ 236.8 million in 2023 to US$ 365.5 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period......."

"...... powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation). Rosuvastat......"

"...... ion in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Atherosclerosis Drugs market, with a systematical descrip......"

"...... during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Statin market, with a systematical description of the status quo and trends of the whole......"

"...... uring the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Ticagrelor market, with a systematical description of the status quo and trends of the who......"

"...... million in 2028, with a CAGR of 9.36% during the forecast years. Atorvastatin Calcium is a drug used to lower blood cholesterol levels and prevent strokes, heart attacks and angina (chest pain). It is also studying the prevention and t......"

"...... Carvedilol is indicated for symptomatic heart failure and for essential hypertension. Report Includes: This report presents an overview of global market for Carvedilol, sales, revenue and price. Analyses of the global ma......"

"...... rgic receptor blocking agents, diuretics, and inotropic drugs are the medications available for the treatment of congestive heart failure. The Congestive Heart Failure Drugs market revenue was XX Million USD in 2022, and will reach XX Million ......"

"...... lication, and consumption area of Abciximab. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies. In Chapter 2.3 of the report, the impac......"